Filing Details

Accession Number:
0001683168-24-000706
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-06 10:27:39
Reporting Period:
2024-02-01
Accepted Time:
2024-02-06 10:27:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1729427 Cns Pharmaceuticals Inc. CNSP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705978 Christopher Downs C/O Cns Pharmaceuticals, Inc.
2100 West Loop South, Suite 900
Houston TX 77027
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-01 66,666 $0.30 103,438 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Warrant to purchase common stock Acquisiton 2024-02-01 66,666 $0.00 66,666 $0.30
Common Stock Series B Warrant to purchase common stock Acquisiton 2024-02-01 66,666 $0.00 66,666 $0.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
94,906 2024-02-01 2029-02-01 No 4 A Direct
161,572 2024-02-01 2025-10-01 No 4 A Direct
Footnotes
  1. The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.